Clinical Trial Update: Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating checkpoint inhibitors for pediatric hepatocellular carcinoma, including fibrolamellar hepatocellular carcinoma, is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrolamellar Hepatocellular Carcinoma
• Hepatocellular Carcinoma

Snippet

Sponsor: Allison O'Neill, MD | Conditions: Hepatocellular Carcinoma, Childhood, Fibrolamellar Carcinoma | Phase 2 | Status: RECRUITING